The first stop for professional medicines advice

Patient Group Directions

139 results

RelevanceNewest firstOldest firstTitle
Applied filters

How to develop a Patient Group Direction

9 June 2022A step by step guide to help organisations and individuals navigate all stages of the PGD development process

Delegating PGD authorisation by a Local Authority

7 March 2022This summary explains why it is not permitted for a Local Authority to delegate the authorisation of PGDs using a Section 75 partnership agreement.

Folic acid 5mg tablets for use during pregnancy

9 February 2022A PGD template, developed by SPS and NHSE and reviewed by the RCOG, for the supply of folic acid 5mg tablets to at risk individuals during pregnancy.

Aspirin tablets for use within antenatal and maternity services

9 February 2022A PGD template, developed by SPS and NHSEI and reviewed by the RCOG, for the supply of aspirin tablets for individuals at high risk of pre-eclampsia

Patient Group Direction use in remote consultations

3 February 2022Advice on managing PGDs during organisational changes to ensure continuity of safe care with overarching good governance.

Managing PGDs following organisational change

3 February 2022Advice on the management of PGDs when there are organisational changes to ensure continuation of safe care and overarching good governance.

Patient Group Directions e-learning programme

8 December 2021E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.

Including more than one medicine in a Patient Group Direction

2 December 2021This article summarises the considerations required if more than one medicine is included within a PGD.

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGD are not legal mechanism for the administration or supply of unlicensed medicines.